|
🐜
|
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
44 auth.
F. V. D. van den Hoogen,
D. Khanna,
J. Fransen,
S. Johnson,
M. Baron,
A. Tyndall,
M. Matucci-Cerinic,
R. Naden,
T. Medsger,
P. Carreira,
G. Riemekasten,
P. Clements,
C. Denton,
O. Distler,
Y. Allanore,
...
D. Furst,
A. Gabrielli,
M. Mayes,
J. V. van Laar,
J. Seibold,
L. Czirják,
V. Steen,
M. Inanç,
O. Kowal-Bielecka,
U. Müller-Ladner,
G. Valentini,
D. Veale,
M. Vonk,
U. Walker,
L. Chung,
D. Collier,
Mary Ellen Csuka,
B. Fessler,
S. Guiducci,
A. Herrick,
V. Hsu,
S. Jimenez,
B. Kahaleh,
P. Merkel,
S. Sierakowski,
R. Silver,
R. Simms,
J. Varga,
J. Pope
|
11 |
2013 |
11
🐜
|
|
🐜
|
An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
44 auth.
F. V. D. Hoogen,
D. Khanna,
J. Fransen,
S. Johnson,
M. Baron,
A. Tyndall,
M. Matucci-Cerinic,
R. Naden,
T. Medsger,
P. Carreira,
G. Riemekasten,
P. Clements,
C. Denton,
O. Distler,
Y. Allanore,
...
D. Furst,
A. Gabrielli,
M. Mayes,
J. M. V. Laar,
J. Seibold,
L. Czirják,
V. Steen,
M. Inanç,
O. Kowal-Bielecka,
U. Müller-Ladner,
G. Valentini,
D. Veale,
M. Vonk,
U. Walker,
L. Chung,
D. Collier,
M. Csuka,
B. Fessler,
S. Guiducci,
A. Herrick,
V. Hsu,
S. Jimenez,
B. Kahaleh,
P. Merkel,
S. Sierakowski,
R. Silver,
R. Simms,
J. Varga,
J. Pope
|
10 |
2013 |
10
🐜
|
|
🐜
|
Cyclophosphamide versus placebo in scleroderma lung disease.
31 auth.
D. Tashkin,
R. Elashoff,
P. Clements,
J. Goldin,
Michael D. Roth,
Daniel E. Furst,
E. Arriola,
R. Silver,
C. Strange,
M. Bolster,
J. Seibold,
David J. Riley,
V. Hsu,
J. Varga,
Dean E. Schraufnagel,
...
A. Theodore,
R. Simms,
R. Wise,
F. Wigley,
B. White,
V. Steen,
C. Read,
Maureen D Mayes,
E. Parsley,
K. Mubarak,
M. Connolly,
J. Golden,
M. Olman,
B. Fessler,
N. Rothfield,
M. Metersky
|
10 |
2006 |
10
🐜
|
|
🐜
|
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
23 auth.
J. Korn,
M. Mayes,
M. Cerinic,
M. Rainisio,
J. Pope,
E. Hachulla,
É. Rich,
P. Carpentier,
J. Molitor,
J. Seibold,
...
V. Hsu,
L. Guillevin,
Sharmila Chatterjee,
H. Peter,
J. Coppock,
A. Herrick,
P. Merkel,
R. Simms,
C. Denton,
D. Furst,
N. Nguyen,
M. Gaitonde,
C. Black
|
9 |
2004 |
9
🐜
|
|
🐜
|
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
44 auth.
Frank J A van den Hoogen,
Dinesh Khanna,
Jaap Fransen,
Sindhu R. Johnson,
Murray Baron,
Alan Tyndall,
M. Matucci-Cerinic,
R. Naden,
Thomas A. Medsger,
Patricia E. Carreira,
G. Riemekasten,
Philip J. Clements,
C. Denton,
Oliver Distler,
Y. Allanore,
...
D. Furst,
Armando Gabrielli,
Maureen D. Mayes,
J. V. Van Laar,
James R. Seibold,
L. Czirják,
Virginia D Steen,
M. Inanc,
O. Kowal-Bielecka,
U. Müller-Ladner,
Gabriele Valentini,
D. J. Veale,
M. Vonk,
Ulrich A. Walker,
Lorinda Chung,
David H. Collier,
M. Csuka,
B. Fessler,
S. Guiducci,
Ariane L. Herrick,
V. Hsu,
Sergio A. Jimenez,
B. Kahaleh,
Peter A. Merkel,
S. Sierakowski,
Richard M. Silver,
Robert W. Simms,
John Varga,
Janet E. Pope
|
9 |
2013 |
9
🐜
|
|
🐜
|
Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised controlled trial
44 auth.
D. P. Tashkin,
Michael D. Roth,
Philip J. Clements,
Daniel E Furst,
D. Khanna,
E. Kleerup,
J. Goldin,
E. Arriola,
E. Volkmann,
S. Kafaja,
R. Silver,
V. Steen,
C. Strange,
R. Wise,
F. Wigley,
...
M. Mayes,
David J. Riley,
S. Hussain,
S. Assassi,
V. Hsu,
B. Patel,
K. Phillips,
F. Martinez,
Jeff rey Golden,
Kari Connolly,
J. Varga,
J. Dematte,
M. Hinchcliff,
A. Fischer,
J. Swigris,
R. Meehan,
A. Theodore,
R. Simms,
S. Volkov,
Dean E. Schraufnagel,
M. Scholand,
T. Frech,
J. Molitor,
K. Highland,
Charles A Read,
Marvin J. Fritzler,
G. H. J. Kim,
C. Tseng,
R. Elashoff
|
9 |
2016 |
9
🐜
|
|
🐜
|
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192.
20 auth.
C. Denton,
P. Merkel,
D. Furst,
D. Khanna,
P. Emery,
V. Hsu,
N. Silliman,
J. Streisand,
J. Powell,
A. Åkesson,
...
J. Coppock,
F. Hoogen,
A. Herrick,
M. Mayes,
D. Veale,
J. Haas,
S. Ledbetter,
J. Korn,
C. Black,
J. Seibold
|
8 |
2007 |
8
🐜
|
|
🐜
|
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
34 auth.
D. P. Tashkin,
R. Elashoff,
Philip J. Clements,
Michael D. Roth,
Daniel E. Furst,
Richard M. Silver,
Jonathan Goldin,
E. Arriola,
Charlie Strange,
M. Bolster,
James R. Seibold,
David J. Riley,
V. Hsu,
John Varga,
Dean E. Schraufnagel,
...
Arthur C. Theodore,
Robert W. Simms,
Robert A. Wise,
F. Wigley,
Barbara White,
Virginia Steen,
Charles A Read,
Maureen D Mayes,
E. Parsley,
Kamal Mubarak,
M. Connolly,
Jeffrey A. Golden,
Mitchell A. Olman,
B. Fessler,
Naomi F. Rothfield,
M. Metersky,
Dinesh Khanna,
Ning Li,
Gang Li
|
8 |
2007 |
8
🐜
|
|
🐜
|
Recombinant Human Relaxin in the Treatment of Scleroderma
20 auth.
J. Seibold,
J. Korn,
R. Simms,
P. Clements,
L. Moreland,
Maureen D. Mayes,
Daniel Furst,
N. Rothfield,
V. Steen,
M. Weisman,
...
D. Collier,
Fredrick Wigley,
P. Merkel,
M. Csuka,
V. Hsu,
S. Rocco,
M. Erikson,
J. Hannigan,
W. S. Harkonen,
Martin E. Sanders
|
8 |
2000 |
8
🐜
|
|
🐜
|
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial
39 auth.
D. Khanna,
C. Spino,
S. Johnson,
L. Chung,
M. Whitfield,
C. Denton,
V. Berrocal,
Jennifer M. Franks,
B. Mehta,
J. Molitor,
V. Steen,
R. Lafyatis,
R. Simms,
Anna Gill,
S. Kafaja,
...
T. Frech,
V. Hsu,
R. Domsic,
J. Pope,
J. Gordon,
M. Mayes,
E. Schiopu,
A. Young,
N. Sandorfi,
Jane Park,
F. Hant,
E. Bernstein,
S. Chatterjee,
F. Castelino,
A. Ajam,
Yue Wang,
Tammara A. Wood,
Y. Allanore,
M. Matucci-Cerinic,
O. Distler,
Ora Singer,
Erica Bush,
D. Fox,
D. Furst
|
7 |
2020 |
7
🐜
|
|
🦁
|
Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
8 auth.
V. Hsu,
A. Moreyra,
Alan C. Wilson,
M. Shinnar,
D. Shindler,
Julianne E. Wilson,
...
A. Desai,
J. Seibold
|
7 |
2008 |
7
🦁
|
|
🐜
|
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
40 auth.
M. Elhai,
M. Boubaya,
O. Distler,
V. Smith,
M. Matucci-Cerinic,
J. J. Alegre Sancho,
M. Truchetet,
Y. Braun-Moscovici,
F. Iannone,
P. Novikov,
A. Lescoat,
E. Siegert,
I. Castellví,
P. Airó,
S. Vettori,
...
E. De Langhe,
E. Hachulla,
A. Erler,
L. Ananieva,
M. Krusche,
F. López-Longo,
J. Distler,
N. Hunzelmann,
A. Hoffmann-Vold,
V. Riccieri,
V. Hsu,
M. Pozzi,
C. Ancuta,
E. Rosato,
C. Mihai,
M. Kuwana,
L. Saketkoo,
C. Chizzolini,
R. Hesselstrand,
S. Ullman,
Ş. Yavuz,
S. Rednic,
C. Caimmi,
C. Bloch-Queyrat,
Y. Allanore
|
7 |
2019 |
7
🐜
|
|
🐜
|
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
17 auth.
E. Volkmann,
D. Tashkin,
M. Sim,
Ning Li,
E. Goldmuntz,
L. Keyes‐Elstein,
A. Pinckney,
D. Furst,
P. Clements,
D. Khanna,
...
V. Steen,
D. Schraufnagel,
S. Arami,
V. Hsu,
M. Roth,
R. Elashoff,
K. Sullivan
|
7 |
2018 |
7
🐜
|
